BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 216 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $6,946,000 | +43.1% | 50,000 | 0.0% | 0.43% | +44.6% |
| Q2 2021 | $4,854,000 | +42.0% | 50,000 | 0.0% | 0.30% | +4.6% |
| Q1 2021 | $3,418,000 | -20.3% | 50,000 | 0.0% | 0.28% | -32.9% |
| Q4 2020 | $4,286,000 | -54.5% | 50,000 | -65.5% | 0.42% | -48.1% |
| Q3 2020 | $9,426,000 | -67.8% | 145,000 | -63.8% | 0.82% | -64.7% |
| Q2 2020 | $29,244,000 | +114.8% | 400,000 | 0.0% | 2.32% | +101.1% |
| Q1 2020 | $13,612,000 | +25.0% | 400,000 | +100.0% | 1.15% | +157.9% |
| Q4 2019 | $10,888,000 | +30.5% | 200,000 | 0.0% | 0.45% | -14.0% |
| Q3 2019 | $8,344,000 | – | 200,000 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
| Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
| ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
| Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
| Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
| Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |